Immunity-and-matrix-regulatory cells promote hyaline-like cartilage repair in osteoarthritis
Source abstract
Abstract
Articular cartilage repair in osteoarthritis (OA) remains a major clinical challenge. Although approaches using mesenchymal stem cells (MSCs) have demonstrated partial efficacy in OA, the regenerated tissue is often unable to form stable hyaline-like cartilage phenotype. Here, we introduce immunity-and-matrix-regulatory cells (IMRCs), derived from human embryonic stem cells (ESCs), as an alternative cell source for OA therapy. Using a multiple-level platform including 2D chondrocytes, 3D OA cartilage organoids (OCOs), rabbit cartilage explants, and a rat OA model, we demonstrate that IMRCs significantly enhance hyaline-like matrix formation while suppressing inflammation, angiogenesis, and fibrotic remodeling. Mechanistically, IMRC-mediated cartilage repair is partially associated with MMP1-dependent matrix remodeling. This study establishes a translational evaluation strategy for IMRCs and points to their potential as an alternative cell source for inducing cartilage repair in OA. Notably, the OCOs established in this study provide a pathologically relevant in vitro platform for evaluating cartilage regeneration in OA.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Immune responses and vaccinations · Mesenchymal stem cell research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (75)
Show source-provided references
1. Global prevalence, incidence, and years lived with disability (YLDs) of osteoarthritis: trends from 1990 to 2021 and projections to 2050
2. The immune microenvironment in cartilage injury and repair10.1016/j.actbio.2021.12.006 ↗
3. Regeneration of articular cartilage defects: therapeutic strategies and perspectives10.1177/20417314231164765 ↗
4. Osteoarthritis10.1038/nrdp.2016.72 ↗
5. Osteoarthritis as a systemic disease10.1038/s41584-025-01332-8 ↗
6. Advances in the pathology and treatment of osteoarthritis10.1016/j.jare.2025.01.053 ↗
7. Natural compounds and mesenchymal stem cells: implications for inflammatory-impaired tissue regeneration10.1186/s13287-024-03641-3 ↗
8. Intraarticular injections of mesenchymal stem cells in knee osteoarthritis: a review of their Current molecular mechanisms of action and their efficacy10.3390/ijms232314953 ↗
9. Efficacy and safety of mesenchymal stem cells in knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials10.1186/s13287-025-04252-2 ↗
10. Bone marrow mesenchymal stem cells overexpressing FGF-2 loaded onto a decellularized extracellular matrix hydrogel for the treatment of osteoarthritis10.1039/D5BM00920K ↗
11. Therapeutic efficacy of extracellular vesicles from hiPSC-derived MSCs in serum-containing and xeno-free media for osteoarthritis treatment10.1186/s13287-025-04890-6 ↗
12. Clinical-grade extracellular vesicles derived from umbilical cord mesenchymal stromal cells: preclinical development and first-in-human intra-articular validation as therapeutics for knee osteoarthritis10.1186/s12951-024-03088-x ↗
13. CytoplastCXCR4: an enucleated self-eliminating and mitochondria delivering strategy for targeted cartilage defect therapy10.1016/j.biomaterials.2026.124167 ↗
14. Tissue engineering strategies hold promise for the repair of articular cartilage injury10.1186/s12938-024-01260-w ↗
15. Stem cell-based cartilage regeneration: biological strategies, engineering innovations, and clinical translation
16. Articular fibrocartilage - why does hyaline cartilage fail to repair?10.1016/j.addr.2018.12.015 ↗
17. Mesenchymal stromal cells: heterogeneity and therapeutical applications10.3390/cells12162039 ↗
18. Mesenchymal stem cells in fibrotic diseases-the two sides of the same coin10.1038/s41401-022-00952-0 ↗
19. Immunity-and-matrix-regulatory cells derived from human embryonic stem cells safely and effectively treat mouse lung injury and fibrosis10.1038/s41422-020-0354-1 ↗
20. The therapeutic effects of human embryonic stem cells-derived immunity-and-matrix regulatory cells on membranous nephropathy10.1186/s13287-022-02917-w ↗
21. Immunity-and-matrix-regulatory cells enhance cartilage regeneration for meniscus injuries: a phase I dose-escalation trial10.1038/s41392-023-01670-7 ↗
22. Optimized administration of human embryonic stem cell-derived immunity-and-matrix regulatory cells for mouse lung injury and fibrosis10.1186/s13287-024-03945-4 ↗
23. Human embryonic stem cell-derived immunity-and-matrix-regulatory cells promote endometrial repair and fertility restoration in IUA rats10.1186/s13287-025-04298-2 ↗
24. Organogenesis in a dish: modeling development and disease using organoid technologies10.1126/science.1247125 ↗
25. Stem cell-derived organoids as a next-generation platform for drug toxicity and efficacy testing: toward replacing animal models in regulatory science10.1002/jat.70059 ↗
26. A review of advanced biomaterials and cells for the production of bone organoid10.1002/smsc.202300027 ↗
27. Engineering bone/cartilage organoids: strategy, progress, and application10.1038/s41413-024-00376-y ↗
28. Clinical-grade iPSC-derived chondrogenic micropellets for treating advanced cartilage defects10.1126/sciadv.adw4911 ↗
29. Single BMSC-derived cartilage organoids for gradient heterogeneous osteochondral regeneration by leveraging native vascular microenvironment10.1186/s12951-025-03403-0 ↗
30. Engineered human osteoarthritic cartilage organoids10.1016/j.biomaterials.2024.122549 ↗
31. Cartilage organoids bridging bench to bedside: a steroid-free strategy for early osteoarthritis repair
32. Cartilage organoids: an emerging platform for novel osteoarthritis therapies10.3389/fcell.2025.1668766 ↗
33. Cell surface markers of mesenchymal stem cells: current knowledge and advances in characterization technologies10.3390/life16010010 ↗
34. The chemokine SDF-1/CXCL12 contributes to the 'homing' of umbilical cord blood cells to a hypoxic-ischemic lesion in the rat brain10.1002/jnr.22292 ↗
35. CXCL12/CXCR4 axis promotes the chemotaxis and phagocytosis of B cells through the PI3K-AKT signaling pathway in an early vertebrate10.4049/jimmunol.2300562 ↗
36. The roles of Integrin α5β1 in human cancer10.2147/OTT.S273803 ↗
37. Visual histological grading system for the evaluation of in vitro-generated neocartilage10.1089/ten.2006.12.2141 ↗
38. A cytokine-induced spheroid-based in vitro model for studying osteoarthritis pathogenesis10.3389/fbioe.2023.1167623 ↗
39. Engineered nasal cartilage for the repair of osteoarthritic knee cartilage defects10.1126/scitranslmed.aaz4499 ↗
40. Enhanced bone regeneration via endochondral ossification using Exendin-4-modified mesenchymal stem cells
41. Engineering of a functional bone organ through endochondral ossification10.1073/pnas.1220108110 ↗
42. NF-κB signaling pathways in osteoarthritic cartilage destruction10.3390/cells8070734 ↗
43. Osteoarthritis: pathogenic signaling pathways and therapeutic targets10.1038/s41392-023-01330-w ↗
44. Smad signaling determines chondrogenic differentiation of bone-marrow-derived mesenchymal stem cells: inhibition of Smad1/5/8P prevents terminal differentiation and calcification10.1089/ten.tea.2010.0043 ↗
45. The roles and regulatory mechanisms of TGF-β and BMP signaling in bone and cartilage development, homeostasis and disease10.1038/s41422-023-00918-9 ↗
46. Roles of matrix metalloproteinases and their natural inhibitors in metabolism: insights into health and disease10.3390/ijms241310649 ↗
47. A human organoid drug screen identifies α2-adrenergic receptor signaling as a therapeutic target for cartilage regeneration10.1016/j.stem.2024.09.001 ↗
48. Large-scale multicenter study reveals anticitrullinated SR-A peptide antibody as a biomarker and exacerbator for rheumatoid arthritis10.1126/sciadv.adr8078 ↗
49. Rational design matrix materials for organoid development and application in biomedicine10.1093/rb/rbaf038 ↗
50. Cartilage organoids for cartilage development and cartilage-associated disease modeling10.3389/fcell.2023.1125405 ↗
51. In situ remodeling of efferocytosis via lesion-localized microspheres to reverse cartilage senescence
52. Clinical phenotypes, molecular endotypes and theratypes in OA therapeutic development10.1038/s41584-024-01126-4 ↗
53. Identification of transcription factors responsible for dysregulated networks in human osteoarthritis cartilage by global gene expression analysis10.1016/j.joca.2018.07.012 ↗
54. Translational genomics of osteoarthritis in 1,962,069 individuals10.1038/s41586-025-08771-z ↗
55. Single-cell transcriptomics reveals novel chondrocyte and osteoblast subtypes and their role in knee osteoarthritis pathogenesis10.1038/s41392-025-02136-8 ↗
56. The role of inflammatory mediators and matrix metalloproteinases (MMPs) in the progression of osteoarthritis
57. Regulation of matrix metalloproteinases: an overview10.1023/A:1026028303196 ↗
58. Recent advances in osteoarthritis research: a review of treatment strategies, mechanistic insights, and acupuncture
59. Anti-inflammatory and immunomodulatory effects of the extracellular vesicles derived from human umbilical cord mesenchymal stem cells on osteoarthritis via M2 macrophages10.1186/s12951-021-01236-1 ↗
60. Chondrogenic commitment of human umbilical cord blood and umbilical cord-derived mesenchymal stem cells induced by the supernatant of chondrocytes: a comparison study10.1002/ame2.12515 ↗
61. Single-cell transcriptome analysis of uncultured human umbilical cord mesenchymal stem cells10.1186/s13287-020-02055-1 ↗
62. Human umbilical cord-derived mesenchymal stem/stromal cells: a promising candidate for the development of advanced therapy medicinal products10.1186/s13287-021-02222-y ↗
63. Umbilical cord-derived stem cells for the treatment of knee osteoarthritis: a systematic review
64. Human umbilical cord mesenchymal stem cells promoting knee joint chondrogenesis for the treatment of knee osteoarthritis: a systematic review10.1186/s13018-023-04131-7 ↗
65. PTHrP targets HDAC4 and HDAC5 to repress chondrocyte hypertrophy10.1172/jci.insight.97903 ↗
66. Inhibitory function of parathyroid hormone-related protein on chondrocyte hypertrophy: the implication for articular cartilage repair10.1186/ar4025 ↗
67. An injectable liposome-anchored teriparatide incorporated gallic acid-grafted gelatin hydrogel for osteoarthritis treatment10.1038/s41467-023-38597-0 ↗
68. MMP13-targeted siRNA-loaded micelles for diagnosis and treatment of posttraumatic osteoarthritis
69. A roadmap of In vitro models in osteoarthritis: a focus on their biological relevance in regenerative medicine10.3390/jcm10091920 ↗
70. Recapitulation of cartilage/bone formation using iPSCs via biomimetic 3D rotary culture approach for developmental engineering10.1016/j.biomaterials.2020.120334 ↗
71. Synergistic promotion of bone regeneration through co-culture of endothelial cells with mesenchymal stem cells in endochondral ossification organoids10.1186/s13287-025-04733-4 ↗
72. In vitro inflammatory multi-cellular model of osteoarthritis10.1016/j.ocarto.2023.100432 ↗
73. Chondrocyte membrane-coated nanoparticles promote drug retention and halt cartilage damage in rat and canine osteoarthritis10.1126/scitranslmed.adh9751 ↗
74. Establishment of an Ex vivo inflammatory osteoarthritis model with human osteochondral explants10.3389/fbioe.2021.787020 ↗
75. The physiological metabolite α-ketoglutarate ameliorates osteoarthritis by regulating mitophagy and oxidative stress10.1016/j.redox.2023.102663 ↗